Attention Bias Modification for Depression
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test two different Attention Bias Modification (ABM) treatments for people with depression. Researchers will compare a gamified version of ABM, delivered via a mobile app, with traditional ABM and a sham (fake) version to determine which is more effective in reducing depressive symptoms. The study will also explore the mechanisms behind these treatments and the duration of their effects. Individuals who have experienced depression symptoms, are fluent in English, and have not recently changed their medication may be suitable candidates. Participants will complete surveys, eye-tracking tasks, and interviews. As an Early Phase 1 trial, this research focuses on understanding how these innovative treatments work in people, offering participants a chance to contribute to groundbreaking mental health research.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you must not have changed your antidepressant medication or dosage in the past 12 weeks to be eligible.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Studies have shown that both game-like and traditional Attention Bias Modification (ABM) treatments are generally easy for people to handle. Research indicates that just one session of the game-like ABM can effectively lower anxiety and stress without major safety concerns. In studies with adults who have depression, traditional ABM has not shown significant side effects, suggesting it is also safe to use.
Since this study is in its early phase, it primarily focuses on assessing the safety and effectiveness of the treatments. Early-phase trials involve careful monitoring to ensure participant safety. Although specific reports of safety issues have not emerged in these studies, researchers are still gathering detailed safety information due to the trial's early stage. Participants can feel reassured that early-phase trials prioritize their safety.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these treatments because they offer a fresh approach to tackling depression by targeting attention biases. Unlike standard treatments like antidepressants or cognitive behavioral therapy, these methods use Attention Bias Modification (ABM) to directly alter how people with depression focus on emotional cues. The gamified ABM stands out by using a mobile app to present happy and sad stimuli, training users to focus more on positive cues in a fun, engaging way. Meanwhile, the traditional ABM offers a web-based program that helps shift attention away from negative emotions, and the sham ABM serves as a control to test the effectiveness of these new methods. This innovative approach could potentially offer a quick, accessible tool to complement traditional therapies for depression.
What evidence suggests that this trial's treatments could be effective for depression?
Research has shown that Attention Bias Modification (ABM) can reduce depression symptoms by altering focus on negative thoughts. This trial will compare different ABM methods. Participants in one arm will use Gamified ABM, which employs a mobile app with interactive features and has shown promise in improving mood by changing negative thought patterns. Another arm will involve Traditional ABM, offered online, which has also been effective in reducing negative thinking and improving brain connections related to mood. Although the results are promising, improvements have been small and varied. Overall, researchers are actively studying ABM treatments for their potential to help with depression by retraining how the brain handles emotional information.13678
Who Is on the Research Team?
Christopher G Beevers, PhD
Principal Investigator
UT Austin
Are You a Good Fit for This Trial?
This trial is for adults with symptoms of depression. Participants will be asked to fill out questionnaires, do eye-tracking tasks, and undergo interviews by clinicians. Details on specific inclusion or exclusion criteria are not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either gamified, traditional, or sham ABM treatments for depression
Follow-up
Participants are monitored for the durability of ABM effects on depression symptoms
What Are the Treatments Tested in This Trial?
Interventions
- Gamified Attention Bias Modification
- Sham Attention Bias Modification
- Traditional Attention Bias Modification
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas at Austin
Lead Sponsor
Arcade Therapeutics
Collaborator